Article Details

Akebia Therapeutics Inc (NASDAQ:AKBA) Expected to Post Quarterly Sales of $93.94 Million

Retrieved on: 2019-09-06 18:52:30

Tags for this article:

Click the tags to see associated articles and topics

Akebia Therapeutics Inc (NASDAQ:AKBA) Expected to Post Quarterly Sales of $93.94 Million. View article details on hiswai:

Excerpt

<div><b>Man Group plc</b> boosted its holdings in shares of Akebia Therapeutics by 58.8% in the 2nd quarter. <b>Man Group plc</b> now owns 934,650 shares of the ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo